Reliable partner for your next business venture

30 YEARS OF EXPERIENCE

CONVENIENTLY LOCATED IN THE CENTER OF EU

READY-TO-USE BIOSIMILARS

RELIABLE GMP SERVICES

Main areas of activities: 

Analytical and EU GMP related services: contract-based batch release testing and EU QP batch release 

Development activities: technologies development and tech transfer (biologicals, biosimilars API, generic final drug product)

Final Products: 

ProBV– in house developed patented protein-based gynecological products for the treatment of bacterial vaginosis, offered as intimate wash and vaginal ovules

Melatonin drug product– eCTD dossier and supply of final product

 

  • Founded in 2007 by leading scientists from Sicor Biotech (TEVA Pharmaceuticals) who led the CMC development of Tevagrastim, one of the first biosimilars in the EU
  • Portfolio of 6 cost-efficient biosimilar technologies offered for out-licensing
  • 1 technology already out-licensed for certain markets!
  • Pipeline of 4 biobetter technologies developed using patented ProMER™ platform, that allows extending biopharmaceuticals’ circulation half-life in plasma
  • Focus on wave 3 biosimilar products (with patents running-out after 2020)
  • EU cGMP certification for batch release and analytical testing
  • Access to cGMP manufacturing to supply clinical and commercial needs
  • In-depth know-how in: high-yield expression system development, easy-to-handle up-stream and down-­stream process development, formulation development and comparability studies